Insider filing · DGX
Mark E Delaney
SVP & Chief Commercial Officer
profile →
Quest Diagnostics Incorporated
DGX · Healthcare · 49 filings in 24 months
ticker →
Mark E Delaney sold $307K of Quest Diagnostics Incorporated (DGX)
Executed May 12 2025, disclosed May 14 2025, 2 days later.
Value, as filed
$307K
1,748 sh across 2 lots
Executed
May 12 2025
the trade date, as filed
Disclosed
May 14 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MDMark E Delaney (SVP & Chief Commercial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Quest Diagnostics Incorporated (DGX). The largest single filing was $1.5M of DGX (7,946 sh × $187.35, as filed), executed Nov 18 2025.
The name
DGXHealthcare · Quest Diagnostics Incorporated provides diagnostic testing and services in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Mark E Delaney in DGX
DGXSALE
Quest Diagnostics Incorporated
$376K1,600 sh × $235.18
Exec Jul 28
Filed Jul 29 · 5:04 PM ET DGXSALE Quest Diagnostics Incorporated $1.5M
7,946 sh × $187.35
Exec Nov 18 2025
Filed Nov 20 2025 · 5:30 PM ET